MORPHOLINE DERIVATIVES AS SIP MODULATORS Russian patent published in 2015 - IPC C07D265/30 C07D265/32 C07D413/12 C07D419/12 C07D471/04 A61K31/5377 A61P25/00 

Abstract RU 2557233 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: in the general formula (I), R1 is specified in cyano, (2-4C)alkynyl, (1-4C)alkyl, (3-6C)cycloalkyl, (4-6C)cycloalkenyl, (6-8C)bicycloalkyl, (8-10C)bicyclic group, each of which can be substituted by (1-4C)alkyl, phenyl, biphenyl, naphthyl each of which can be substituted by three substitutes independently specified in halogen, (1-4C)alkyl substituted as may be necessary by one or more atoms of fluorine, (2-4C)alkynyl, (1-4C)alkoxy substituted as may be necessary by one or more atoms of fluorine, amino, di(1-4C)alkylamino and (3-6C)cycloalkyl, phenyl substituted by phenoxy, benzyl, benzyloxy, phenylethyl or a monocyclic heterocycle, each of which can be substituted by (1-4C)alkyl, 5-6-merous monocyclic heterocycle containing 1-3 heteroatoms specified in N, O and S substituted as may be necessary by a halogen, (1-4C)alkyl or phenyl substituted as may be necessary by (1-4C)alkyl, and 9-10-merous bicyclic heterocycle containing 1-2 heteroatoms specified in N and O substituted as may be necessary by (1-4C)alkyl; A is specified in -CO-O-, -NH-CO-, -CO-NH, -C=C-, -CCH3-O- and a binding group -Y-(CH2)n-X-, wherein Y is attached to R1 and specified in a bond, -O-, -SO2-, -CH2-O-, -CO-, -CO-O-, -CO-NH-, -NH-CO-, -C=C- and -C≡C-; n means an integer from 1 to 7; and X is attached to a phenylene group and specified in a bond, -O-, -S-, and -NH; the ring structure B represents phenylene; R2 means H, (1-4C)alkyl substituted as may be necessary by one or more atoms of fluorine, (1-4C)alkoxy or halogen; and R3 means (1-4C)alkylene-R5, wherein the alkylene group can be substituted by one or more atoms of a halogen, or R3 means (3-6C)cycloalkylene-R5 or -CO-CH2-R5, wherein R5 means -OH, -PO3H2, -OPO3H2, -COOH or tetrazol-5-yl; R4 means H or (1-4C)alkyl; R6 means one or more substitutes independently specified in H, (1-4C)alkyl or oxo; W means -O- or -S-.

EFFECT: invention refers to (thio)morpholine derivatives of formula (I) possessing the property of a sphingosine-1-phosphate (S1P) modulator, a based pharmaceutical composition and using them.

18 cl, 1 dwg, 237 ex

Similar patents RU2557233C2

Title Year Author Number
SPIROCYCLIC AMINE DERIVATIVES AS S1P MODULATORS 2011
  • Stojt Aksel
  • Ivema Bakker Vauter I.
  • Kolen Khejn K.A.S.
  • Van Dongen Maria J.P.
  • Leflemme Nikolas J.-L.D.
  • Khobson Edrian
RU2602800C2
SUBSTITUTED PYRAZOLES 2001
  • Brajtenbukher Dzh. Gaj
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Grajs Cheril A.
  • Gastin Darin Dzh.
  • Kkhatuja Kharipada
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Tehjs Kevin L.
  • Vej Dzhianmej
RU2286343C2
SUBSTITUTED MORPHOLINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF COUNTERACTION TO SUBSTANCE P OR INHIBITION OF NEUROKININ-1 RECEPTORS 1995
  • Konrad P. Dorn
  • Dzheffri Dzh. Khejl
  • Mal'Kol'M Makkoss
  • Sander G. Mills
RU2170233C2
METHOD FOR TREATMENT ALLERGY BY USING SUBSTITUTED PYRAZOLES 2001
  • Brajtenbukher Dzh. Gaj
  • Kaj Kh'Jui
  • Ehdvards Dzhejms P.
  • Grajs Cheril A.
  • Gu Jin
  • Gastin Darin Dzh.
  • Karlsson Lars
  • Kkhatuja Kharipada
  • Meduna Stiven P.
  • Pajo Barbara A.
  • Sun Sikvan
  • Tehjs Kevin L.
  • Termond Robin L.
  • Vej Dzhianmej
RU2277909C2
NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND USE THEREOF IN INCREASING ENDOGENOUS ERYTHROPOIETIN 2004
  • Arend Mikhel' P.
  • Flippin Li A.
  • Gjuntsler-Pukall' Fol'Kmar
  • Kho Vehn'-Bin'
  • Tertl Ehrik D.
  • Du Sjaokhoj
RU2379291C2
AROMATIC 6,7-DISUBSTITUTED 3-QUINOLINECARBOXAMIDE DERIVATIVES, METHOD FOR PRODUCTION THEREOF (VARIANTS), PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USE THEREOF IN DRUG MANUFACTURING 2002
  • Larsson Joakim
  • She Peter
RU2281940C2
DERIVATIVES OF PYRIMIDINE, PHARMACEUTICAL COMPOSITION AND METHOD OF PROPHYLAXIS AND TREATMENT OF DISEASE 1996
  • Mitsuteru Khirata
  • Takeo Deusi
  • Josio Takakhasi
  • Masakhiro Tamura
  • Takesi Okhsima
  • Tosiaki Oda
  • Tetsuja Isikava
  • Khirojuki Sonoki
  • Masami Siratsuti
RU2170734C2
ARYLCARBONYL DERIVATIVES AS THERAPEUTIC AGENTS 2003
  • Polizetti Dkharma Rao
  • Kodra Janos Tibor
  • Lau Jesper
  • Blok Pav
  • Val'Karse-Lopes Marija Karmen
  • Blume Nil'S
  • Guzel' Mustafa
  • Santosh Kalpati Chidambaresvaran
  • Mdzhalli Adnan M. M.
  • Ehndrjus Robert Karl
  • Subramanian Govindan
  • Ankersen Mikhael'
  • Vedse Per
  • Mjurrehj Ehntoni
  • Jeppesen Lone
  • Lau Jesper
RU2340605C2
NITROGEN-CONTAINING HETEROARYL DERIVATIVES 2004
  • Roberts Kristofer Don
  • Chzhi Dun-Fan
  • Griffit Ronald Konrad
RU2375350C2
BENZYLAMINE DERIVATIVES AS INHIBITORS OF PLASMA KALLIKREIN 2012
  • Evans Devid Majkl
  • Dejvi Rebekka Luiz
  • Edvards Khannakh Dzhoj
  • Ruker Devid Filip
RU2607045C2

RU 2 557 233 C2

Authors

Ivema Bakker Vauter I.

Kolen Khejn K.A.S.

Mons Kharmen

Stojt Aksel

Ronken Ehrik

Van Der Kam Ehlizabet

Frankena Jur'En

Khobson Ehdrian D

Dates

2015-07-20Published

2010-08-27Filed